Evaluating CMR
Metabolic Syndrome and Type 2 Diabetes/CVD Risk
IDF
- 1Key Points (1 page)
- 2IDF Clinical Criteria for Diagnosing the Metabolic Syndrome (1 page)
- 3Etiology and treatment of the metabolic syndrome and its components according to the IDF (3 pages)
- 4IDF clinical tools for diagnosing the metabolic syndrome and type 2 diabetes/CVD risk (3 pages)
- 5References (1 page)
Key Points
Page:
1 of 9
1 of 9
- Waist girth is a mandatory feature of International IDF clinical criteria for diagnosing the metabolic syndrome.
- For the first time, population-specific cut-offs have been proposed to consider ethnic differences in the relationship between abdominal obesity and incidence of CHD and type 2 diabetes.
- IDF clinical criteria are similar to those proposed by the NCEP-ATP III regarding metabolic markers used to diagnose the metabolic syndrome.
- When managing the metabolic syndrome, the first step should be to reduce intra-abdominal (visceral) adipose tissue through lifestyle modification.
- Most prospective studies have found a positive relationship between the metabolic syndrome (IDF criteria) and CVD.
- Further research is required to establish specific waist circumference cut-offs for all regions of the world.
Page:
1 of 9
1 of 9
How feasible do you think it will be to incorporate imaging technologies in the assessment of patients' global CVD risk? By John J. Kastelein, MD
More
Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality. Heart 2008;94:457-62
More
Evidence for a greater relative accumulation of intra-abdominal adipose tissue (AT) in Japanese than Caucasian Americans
More